|
09/09/2024
|
07:00
|
Update re Equity Issuance, Secondary Sale and the board
|
PR Newswire
|
|
08/08/2024
|
15:37
|
Strategic Advisory Board & Appointment of Director
|
PR Newswire
|
|
29/07/2024
|
16:31
|
£40.0m Equity Issuance and £29.4m Secondary Sale
|
PR Newswire
|
|
18/07/2024
|
07:00
|
Employee Long Term Incentive Plan and Issue of Equity
|
PR Newswire
|
|
28/06/2024
|
15:45
|
Result of AGM
|
PR Newswire
|
|
11/06/2024
|
14:42
|
Holding(s) in Company
|
PR Newswire
|
|
11/06/2024
|
07:00
|
Holding(s) in Company
|
PR Newswire
|
|
11/06/2024
|
07:00
|
Holding(s) in Company
|
PR Newswire
|
|
11/06/2024
|
07:00
|
Holding(s) in Company
|
PR Newswire
|
|
05/06/2024
|
07:00
|
Final Results and Notice of AGM
|
PR Newswire
|
|
30/05/2024
|
15:30
|
Holding(s) in Company
|
PR Newswire
|
|
10/04/2024
|
07:00
|
4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
|
PR Newswire
|
|
21/03/2024
|
07:00
|
4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
|
PR Newswire
|
|
01/03/2024
|
07:00
|
4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
|
PR Newswire
|
|
06/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
06/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
06/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
06/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
06/02/2024
|
07:00
|
Exercise of Options
|
PR Newswire
|
|
05/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
05/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
05/02/2024
|
07:01
|
Holding(s) in Company
|
PR Newswire
|
|
05/02/2024
|
07:00
|
Directors' Dealings
|
PR Newswire
|
|
02/02/2024
|
07:00
|
Long-Term Incentive Plan and Exercise of Options
|
PR Newswire
|
|
21/09/2023
|
07:00
|
Half-year Report
|
PR Newswire
|
|
01/08/2023
|
07:00
|
Grant received from the Bill and Melinda Gates Foundation
|
PR Newswire
|
|
14/06/2023
|
12:52
|
Result of AGM
|
PR Newswire
|
|
25/05/2023
|
07:00
|
Neomatrix Product Supply Agreement
|
PR Newswire
|
|
11/05/2023
|
07:00
|
Final Results and Related Party Transaction
|
PR Newswire
|
|
03/04/2023
|
12:11
|
New lease and expansion of manufacturing capacity
|
PR Newswire
|
|
31/03/2023
|
07:00
|
Holding(s) in Company
|
PR Newswire
|
|
09/02/2023
|
07:00
|
Holding(s) in Company
|
PR Newswire
|
|
09/02/2023
|
07:00
|
Exercise of Options and Issue of Equity
|
PR Newswire
|
|
09/02/2023
|
07:00
|
Holding(s) in Company
|
PR Newswire
|
|
30/09/2022
|
07:00
|
Half-year Report
|
PR Newswire
|
|
27/09/2022
|
09:05
|
Second Price Monitoring Extn
|
RNS
|
|
27/09/2022
|
09:00
|
Price Monitoring Extension
|
RNS
|
|
13/07/2022
|
07:00
|
Director/PDMR Shareholding
|
PR Newswire
|
|
16/06/2022
|
15:28
|
Director/PDMR Shareholding
|
PR Newswire
|
|
10/06/2022
|
07:00
|
Research Collaboration
|
PR Newswire
|
|
09/06/2022
|
11:39
|
Result of AGM
|
PR Newswire
|
|
12/05/2022
|
14:27
|
Director/PDMR Shareholding
|
PR Newswire
|
|
11/05/2022
|
11:57
|
Director/PDMR Shareholding
|
PR Newswire
|
|
09/05/2022
|
07:00
|
Final Result and Notice of AGM
|
PR Newswire
|
|
06/05/2022
|
14:00
|
Price Monitoring Extension
|
RNS
|
|
27/04/2022
|
07:00
|
Joint Development Agreement with Heqet Therapeutics
|
PR Newswire
|
|
23/03/2022
|
07:00
|
Rapidly Produced Customisable Synthetic DNA
|
PR Newswire
|
|
15/03/2022
|
16:41
|
Second Price Monitoring Extn
|
RNS
|
|
15/03/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
15/03/2022
|
14:05
|
Second Price Monitoring Extn
|
RNS
|